Future Market Insights
Search Reports

Enteric Softgel Capsules Market

Starting at US$ 5000

Buy Now
Companies
Industry Size (2025)
USD 350.8 Mn
Forecast (2035)
USD 658.5 Mn
CAGR (2025 to 2035)
6.5%

Enteric Softgel Capsules Market Outlook 2025 to 2035

Enteric softgel capsules market will continue to grow and will maintain steady growth from 2025 to 2035. The rising need for targeted drug delivery systems, increased prevalence of gastrointestinal disorders, and high consumption of pharmaceuticals and nutraceuticals contribute to the increasing demand for enteric softgel capsules in the market.

Enteric softgel capsules are acid resistant and dissolve in the intestine for active ingredients, which means that absorption occurs where it is most effective, thus improving bioavailability and minimizing gastric irritation.

The ever-growing use of those enteric soft gels in protecting sensitive compounds such as probiotics, enzymes, and omega-3 fatty acids, besides its uses in oral formulations to deliver NSAIDs, antibiotics, and anticancer agents, would improve global adoption.

It is accompanied in this growth by innovations in the manufacture of capsules with plant-based shells and by the consumer preference for easy-to-swallow tasteless dosage forms.

The enteric softgel capsules market is projected to grow at a CAGR of 6.5%, increasing from USD 350.8 million in 2025 to approximately USD 658.5 Million by 2035.

Key Market Metrics

Metric Value
Market Size in 2025 USD 350.8 Million
Projected Market Size in 2035 USD 658.5 Million
CAGR (2025 to 2035) 6.5%

Regional Market Trends

North America

North America is the major region in the enteric softgel capsules market propelled by advanced pharmaceutical manufacturing and strong nutraceutical demand, together with the high level of consumer awareness regarding GI-friendly delivery systems.

The USA occupies the greatest share in this region, as dietary supplements, prescription medications, and OTC digestive products are widely utilized across the nation. The USA high prevalence of gastrointestinal disorders and supplement consumption are continuously sustaining the demand for enteric delivery technologies, according to the WHO.

Europe

Europe has a stronghold upon said market, aided largely by approval of modern excipients, an aging populace, and strong demand for controlled-release oral therapies. Germany, UK, and Italy stand out as the top consumers of enteric softgel formats in the pharma and nutraceutical industries.

Reports by WHO show that innovation in capsule design and coating technologies in Europe are directed by concern for gut health, preventive healthcare, and patient-centric drug formulations.

Asia-Pacific

Asia-Pacific is the most rapidly growing region due to expanding generic drug manufacturing, increasing supplementation usage, and the growing awareness of GI-targeted formulations. India, China, and Japan significantly contribute, as local pharmaceutical players are investing in encapsulation and coating capabilities. The UN notes the rapid growing middle class and healthcare expenditure of the region are also increasing demand for high-quality GI-tolerant formulations, including enteric soft gels.

Challenges and Opportunities

Challenges

Manufacturing complexity, cost barriers, and regulatory variation

Manufacturing enteric-coated soft-gel capsules is complex and requires specialized formulation techniques and equipment, increasing capital investment and operational complexity. There could be several challenges for small and mid-size manufacturers to scale up enteric production while assuring quality and consistency.

The upside actually proves to be more challenging, with inconsistencies in regulatory definitions and acceptance of enteric coatings across the different marketplaces globally. WHO suggest providing field support in harmonizing excipient standards and regulatory pathways to support rational access to advance oral delivery formats.

Opportunities

Nutraceutical expansion, vegan formulations, and personalized medicine

The entering of new avenues for enteric capsules with the increasing rise in the nutraceutical market, especially in probiotics, enzymes, and herbal extractions, is the boom in new opportunities. Innovations in softgel that contain vegan gelatin-free ingredients appeal more to their target consumers who are dietary and ethical adherents.

Personalized medicine also has future opportunities in the manufacture of enteric capsules., such as pH responsive and time delayed formulations. WHO mentioned that improved oral drug adherence and patient satisfaction by smart capsule delivery will be among the most fundamental contributors of future pharmaceutical success.

Shifts in the Market from 2020 to 2024 and Future Trends 2025 to 2035

The rise in consumption of supplements during the pandemic had renewed interest in this market segment during 2020 to 2024 as enteric softgel capsules. Most of these products were aimed at boosting the immune system and enhancing gut health. Pharmaceutical players even tried enteric formats to include pH-sensitive APIs and for some extended-release applications.

The future trend of the market is in the development of eco-friendly capsules, plants-based coatings, and AI-assisted architecture of capsules. Simulation technology will improve dissolution profiles, stability, and speed to market through smart manufacturing, automation, and predictive modeling.

Market Shifts: A Comparative Analysis 2020 to 2024 vs. 2025 to 2035

Market Shift 2020 to 2024 Trends
Regulatory Landscape Focus on excipient safety and acid-resistance standards
Consumer Trends Growth in probiotic and enzyme supplements
Industry Adoption Pharma and dietary supplement manufacturers
Supply Chain and Sourcing Centralized gelatin capsule production
Market Competition Led by capsule OEMs and softgel brands
Market Growth Drivers Gut health awareness and oral therapy demand
Sustainability and Impact Growing scrutiny over animal-derived gelatin
Smart Technology Integration Basic encapsulation and manual QC
Sensorial Innovation Smooth, tasteless capsules with delayed release
Market Shift 2025 to 2035 Projections
Regulatory Landscape Harmonized global guidance for enteric polymers and coatings
Consumer Trends Rise in personalized capsules and clean-label, vegan formulations
Industry Adoption Expansion into contract manufacturing, functional foods, and gene therapy
Supply Chain and Sourcing Growth of local, plant-based softgel manufacturing networks
Market Competition Entry of biotech, functional nutrition, and personalized health startups
Market Growth Drivers AI-assisted formulation, low-acid drug delivery, and global aging trends
Sustainability and Impact Biodegradable coatings and recyclable blister packaging
Smart Technology Integration Real-time coating validation and pH-controlled micro-delivery systems
Sensorial Innovation Smart coatings that trigger release via pH, microbiome, or time signals

Country-wise outlook

United States

The USA enteric softgel capsules market has been making gradual progress owing to rising demand for wide-ranging controlled-release formulations and improved drug absorption technologies. Most pharmaceutical and nutraceutical companies are now applying enteric coatings to protected acid-sensitive ingredients such as probiotics, fish oils, and some APIs.

According to OECD, innovation in polymer sciences and patients' compliance needs are driving the development of delayed-release capsules. Other motives include the emphasis of the FDA on bioavailability and manufacturing quality in relation to such products being in great acceptance in chronic therapy segments including gastrointestinal, cardiovascular, and immune health.

Country CAGR (2025 to 2035)
United States 6.8%

United Kingdom

In the UK, enteric softgel capsules are becoming more popular in prescription and OTC areas, specifically incorporating omega-3 supplements and enzymes, as well as anti-inflammatory drugs. Consumer safety and quality manufacturing under the MHRA have been the key source of encouragement for the promotion of gastro-resistant capsules, according to OECD.

The aging population and the increasing requirement for individualized dosage forms that lessen gastrointestinal discomfort have also contributed to the growing market. Meanwhile, local manufacturers and CMOs are focusing on superior precision in encapsulation technologies that offer improved stability and absorption.

Country CAGR (2025 to 2035)
United Kingdom 6.3%

European Union

The European Union market of enteric softgel capsules is growing due to the increasing production of pharmaceutical and nutraceutical products across Germany, France, and the Netherlands. According to UN, such EU directives are drawing forward entry into enterically delivered systems that are likely to propel bioavailability and adherence to therapy.

Application expansion is being especially favored by proton pump inhibitors, fat-soluble vitamins, and botanical extracts. Plant-based and allergen-free capsule material innovations are also helping to escalate demand among vegan and health-conscious consumers.

Country CAGR (2025 to 2035)
European Union 6.5%

Japan

The Japan's market for enteric softgel capsules is growing steadily in parallel with the high drug delivery standards and consumer preference for exact low-irritation formulation. Japanese pharmaceutical companies use enteric-coated soft gels in diseases related to the gastrointestinal tract supplement companies market them with probiotic and enzyme applications, according to OECD.

Regulatory backing and the diffusion of these products in old care assure a steady flow of demand. The domestic R&D is focusing on odor masking, dual-release mechanism, and polymer innovations.

Country CAGR (2025 to 2035)
Japan 6.2%

South Korea

The South Korean enteric softgel capsules market is currently getting developed in respect of growing health awareness, innovation in diet supplements, and increased exports of pharmaceuticals. The OECD indicated that the Korean government actively supports research on advanced formulations and bioavailability, thus contributing to local manufacturing of enteric-coated capsules.

It has captured the consumers' favor due to its digestive tolerance and efficacy improvement, especially in functional food and OTC sectors. Manufacturers are developing enteric capsules to ensure clean-label ingredients in meeting the growing consumer demand for natural formulations.

Country CAGR (2025 to 2035)
South Korea 6.7%

Segmentation Outlook - Enteric Softgel Capsules Market

Gelatin capsules and health supplement applications drive global growth through enhanced bioavailability, patient compliance, and integration into preventive healthcare strategies

The enteric softgel capsules market is progressively growing because of consumer as well as healthcare provider preference towards the effective delivery systems for such actives that are sensitive. They are enteric softgel capsules that manage to carry their loads intact through the acidic stomach only to be released in the intestine where they are optimally absorbed.

Gelatin capsules and health supplements command a dominant market share segment of the global market in terms of type of product and application owing to their demonstrated efficacy, consumer acceptance, and conformity with the prevailing wellness trends, but also support improved bioavailability of nutrients, GI side effects, and compliance with dietary regimens.

The greatest potential remains with health supplements in whole gelatin-based enteric softgel capsules, which symbolize the most potential advances in nutritional support with patient well-being, against the growing demand both for targeted delivery systems and preventive healthcare solutions.

Gelatin capsules dominate product use due to superior biocompatibility, ease of manufacturing, and widespread consumer acceptance

Product Type Market Share (2025)
Gelatin Capsules 68.5%

Gelatin capsules lead the enteric softgel capsules market by offering a reliable and efficient medium for encapsulating a variety of active ingredients. Derived from animal collagen, gelatin provides excellent film-forming properties, ensuring capsule integrity and controlled release profiles.

The domination of gelatin capsules is attributed to their affordability, possibilities in production of scale, and long histories in the pharmaceutical and nutraceutical industries. Their compatibility with a plethora of formulations makes them a system of choice among manufacturers willing to deliver quality enteric-coated products.

Health supplements dominate application use due to rising consumer focus on preventive care, nutritional deficiencies, and demand for targeted nutrient delivery

Application Market Share (2025)
Health Supplements 66.2%

Health supplements form the biggest application segment in the enteric softgel capsules market, underlined by rising awareness on the need for nutrition for health and prevention of disease. Enteric-coated capsules are particularly useful to deliver sensitive nutrients destroyed by stomach acid or those which irritate.

The growing trend of self-directed health care also favors the use of health supplements, where individuals take charge of their wellness through dietary supplementation. Enteric softgel capsules maximize the benefits of these supplements by delivering the active ingredients to the site of utmost absorption, thereby maximizing benefits for health.

Competitive Outlook

The enteric softgel capsule market is witnessing growth as demand rises for advancements in oral drug delivery systems aimed at improving bioavailability, protecting acid-sensitive compounds, and alleviating gastrointestinal irritation.

Enteric-coated soft gels are used in pharmaceuticals, nutraceuticals, and dietary supplements for the delayed or targeted delivery of ingredients such as probiotics, omega-3s, enzymes, and non-steroidal anti-inflammatory drugs (NSAIDs). Innovations such as plant-based gelatin alternatives, multi-compartment capsules, and sustained-release formats are key driving forces.

Improving drug stability and gastrointestinal targeting by enteric delivery systems, according to WHO, will enhance patient adherence and therapeutic outcomes.

Market Share Analysis by Key Players & Softgel Capsule Manufacturers

Company Name Estimated Market Share (%)
Catalent, Inc. 14-17%
Lonza Group Ltd. (Capsugel) 11-14%
Sirio Pharma Co., Ltd. 9-12%
Aenova Group 7-10%
EuroCaps Ltd. 6-9%
Other Providers 38-45%

Key Company & Enteric Softgel Capsules Market Solutions

Company Name Key Offerings/Activities
Catalent, Inc. In 2024, launched OptiGel® DR platform for acid-sensitive active ingredients in 2025, expanded plant-based enteric soft gels for vegan nutraceutical formulations.
Lonza Group Ltd. (Capsugel) In 2024, enhanced DUOCAP® capsule-in-capsule technology for sequential delivery in 2025, introduced enteric soft gels with multi-layer film coating for dual-release functionality.
Sirio Pharma Co., Ltd. In 2024, scaled production of probiotic enteric soft gels for Asia-Pacific exports in 2025, launched omega-3 EPA/DHA capsules with odor-blocking enteric coating.
Aenova Group In 2024, added enteric softgel capacity for contract manufacturing of gastro-resistant drugs in 2025, implemented continuous coating technology for uniform batch control.
EuroCaps Ltd. In 2024, developed enteric gelatin alternatives using carrageenan blends in 2025, introduced mini soft gels with enteric release for pediatric and geriatric patients.

Key Market Insights

Catalent, Inc. (14-17%)

Catalent is a global leader in advanced oral dosage form development, offering OptiGel® and customized enteric coating solutions for soft gels used in pharmaceuticals and supplements. Its platforms are widely adopted for enhancing ingredient stability and absorption.According to WHO, enteric drug delivery plays a key role in protecting therapeutic compounds and improving patient comfort during long-term treatments.

Lonza Group Ltd. (Capsugel) (11-14%)

Lonza provides proprietary capsule technologies including DUOCAP® and Licaps® systems tailored for controlled release, combination dosing, and targeted delivery. Its enteric soft gels support complex formulations in digestive health and inflammation management.According to UN, innovations in capsule delivery contribute to better medication adherence in aging and chronic disease populations.

Sirio Pharma Co., Ltd. (9-12%)

Sirio is a major contract manufacturer of nutraceutical soft gels with growing expertise in enteric encapsulation of sensitive compounds. Its offerings are customized for probiotics, fish oil, and plant extracts requiring protection from gastric degradation. According to OECD, enhanced bioavailability through encapsulation technology improves therapeutic efficiency and reduces dosing frequency.

Aenova Group (7-10%)

Aenova specializes in contract manufacturing of enteric-coated dosage forms for pharmaceutical clients. Its softgel services include formulation, coating, stability testing, and regulatory support for gastro-sensitive drugs and supplements. According to WHO, scalable and GMP-compliant softgel platforms are essential for accessible global supply of enteric medications.

EuroCaps Ltd. (6-9%)

EuroCaps offers niche softgel formats including enteric-coated capsules for pediatric, geriatric, and allergy-sensitive populations. Its innovations in plant-based capsules align with rising demand for clean-label and vegan formulations. According to World Bank Report, improving dosage form accessibility and tolerability supports inclusive healthcare outcomes across age groups.

Other Key Players (38-45% Combined)

A range of regional CDMOs and dietary supplement formulators support global enteric softgel production. These include:

  • ProCaps Laboratories-Plant-based and acid-resistant soft gels for DTC wellness brands.
  • Elnova Pharma-Customized enteric capsules for pain relief and GI-sensitive drugs.
  • Sami-Sabinsa Grou-Ayurvedic and botanical enteric soft gels for functional health markets.
  • Best Formulations-Vegan and Kosher-certified enteric soft gels for the USA wellness sector.
  • Erbozeta S.p.A.-European supplier of enteric probiotic and enzyme capsules for medical food applications.

Key Segmentation

By Product:

  • Gelatin Softgel Capsules
  • Vegetarian Softgel Capsules

By Raw Material:

  • Type-A Gelatin (Pork Skin)
  • Type-B Gelatin (Animal Bones and Skin)
  • Fish Bone Gelatin
  • Cellulose Derivatives
  • Starch Material

By Application:

  • Antacid and Antiflatulent Preparations
  • Anti-inflammatory Drugs
  • Antibiotic and Antibacterial Drugs
  • Cough and Cold Preparations
  • Health Supplements
  • Vitamin and Dietary Supplements
  • Other Therapeutic Applications

By End User:

  • Pharmaceutical Companies
  • Nutraceutical Companies
  • Cosmeceutical Companies
  • Food Industry

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

What was the overall size of the enteric softgel capsules market in 2025?

The overall market size for the enteric softgel capsules market was approximately USD 350.8 million in 2025.

How big is the enteric softgel capsules market expected to be in 2035?

The enteric softgel capsules market is expected to reach approximately USD 658.5 million by 2035.

What will drive the demand for the enteric softgel capsules market during the forecast period?

The demand for enteric softgel capsules is rising due to the increasing prevalence of gastrointestinal disorders, the need for targeted drug delivery systems, and the growing consumption of health supplements.

List the top 5 countries contributing to the enteric softgel capsules market.

The top 5 countries driving the development of the enteric softgel capsules market are the United States, Germany, China, Japan, and the United Kingdom.

Which segment in the product type and application is expected to lead in the enteric softgel capsules market?

Gelatin capsules and health supplement applications are expected to command significant shares over the assessment period.

Preview the report firsthand - request a free sample

Get Sample

Get the brochure for pricing and purchase details.

Future Market Insights

Enteric Softgel Capsules Market